Genome sequencing identify chromosome 9 inversions disrupting ENG in 2 unrelated HHT families.

Genome sequencing HHT Inversion

Journal

European journal of medical genetics
ISSN: 1878-0849
Titre abrégé: Eur J Med Genet
Pays: Netherlands
ID NLM: 101247089

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 25 07 2023
revised: 05 01 2024
accepted: 04 02 2024
pubmed: 15 2 2024
medline: 15 2 2024
entrez: 14 2 2024
Statut: ppublish

Résumé

Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber disease, is a dominant inherited vascular disorder. The clinical diagnosis is based on the Curaçao criteria and pathogenic variants in the ENG and ACVRL1 genes are responsible for most cases of HHT. Four families with a negative targeted gene panel and selected by a multidisciplinary team were selected and whole-genome sequencing was performed according to the recommendations of the French National Plan for Genomic Medicine. Structural variations were confirmed by standard molecular cytogenetic analysis (FISH). In two families with a definite diagnosis of HHT, we identified two different paracentric inversions of chromosome 9, both disrupting the ENG gene. These inversions are considered as pathogenic and causative for the HHT phenotype of the patients. This is the first time structural variations are reported to cause HHT. As such balanced events are often missed by exon-based sequencing (panel, exome), structural variations may be an under-recognized cause of HHT. Genome sequencing for the detection of these events could be suggested for patients with a definite diagnosis of HHT and in whom no causative pathogenic variant was identified.

Identifiants

pubmed: 38355093
pii: S1769-7212(24)00011-9
doi: 10.1016/j.ejmg.2024.104919
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104919

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

M Tusseau (M)

Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France; Laboratoire AURAGEN, Lyon, France.

M Eyries (M)

Department of Medical Genetics, AP-HP Sorbonne University, Paris, France; Laboratoire Multisites SeqOIA, Paris, France.

N Chatron (N)

Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France; Laboratoire AURAGEN, Lyon, France.

F Coulet (F)

Department of Medical Genetics, AP-HP Sorbonne University, Paris, France; Laboratoire Multisites SeqOIA, Paris, France.

A Guichet (A)

Service de Génétique Médicale, CHU D'Angers, Angers, France.

E Colin (E)

Service de Génétique Médicale, CHU D'Angers, Angers, France.

B Demeer (B)

Genetics Department, CLAD Nord de France, CHU Amiens, France; CHIMERE, UR UPJV 7516, Université Picardie Jules Verne, Amiens, France.

H Maillard (H)

Department of Internal Medicine and Clinical Immunology, Referral Centre for Rare Systemic Autoimmune Diseases for North and North-West France (CeRAINO), CHU Lille, 59000, Lille, France.

J Thevenon (J)

Laboratoire AURAGEN, Lyon, France.

C Lavigne (C)

Department of Internal Medicine and Clinical Immunology, Angers University Hospital, Angers, France.

V Saillour (V)

Laboratoire Multisites SeqOIA, Paris, France.

C Paris (C)

Laboratoire AURAGEN, Lyon, France.

J M De Sainte Agathe (JM)

Department of Medical Genetics, AP-HP Sorbonne University, Paris, France; Laboratoire Multisites SeqOIA, Paris, France.

M Pujalte (M)

Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France; Laboratoire AURAGEN, Lyon, France.

A Guilhem (A)

Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France.

S Dupuis-Girod (S)

Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France.

G Lesca (G)

Hospices Civils de Lyon, Department of Medical Genetics and National HHT Reference Center, University Hospital of Lyon, Lyon, France; Laboratoire AURAGEN, Lyon, France. Electronic address: gaetan.lesca@chu-lyon.fr.

Classifications MeSH